Real-world outcomes of cilta-cel versus BCMA-targeting bispecific antibodies in relapsed/refractory multiple myeloma.
Saved in:
| Title: | Real-world outcomes of cilta-cel versus BCMA-targeting bispecific antibodies in relapsed/refractory multiple myeloma. |
|---|---|
| Authors: | Tan, Jia Yi1 (AUTHOR), Vignarajah, Aravinthan2 (AUTHOR), Ng, Lay She3 (AUTHOR), Nurliyanah, Atiqah4 (AUTHOR), O’Leary, Daniel5 (AUTHOR), Hilal, Talal6 (AUTHOR) hilal.talal@mayo.edu |
| Source: | Leukemia & Lymphoma. May2026, p1-4. 4p. 1 Illustration. |
| Database: | Academic Search Ultimate |
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2026.2673104 |
